Sort
21,281 grants matching “influenza”
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
$833,113Christopher B Fox · Access To Advanced Health Institute · R01 · FY2021 · AI
Genetics of Coxiella burnetii
$832,831Robert A Heinzen · Niaid Extramural Activities · Z01 · FY2007 · AI
Administrative Core
$832,784Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$832,784Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
$832,698Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2017 · AI
Phase II Trial of H7N9 Influenza Vaccines - VTEU
$832,511David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2014 · AI
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$832,426Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2019 · GM
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$832,426Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2020 · GM
Pathogen Discovery in Emerging Infectious Diseases
$832,044W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2012 · AI
Strengthening Avian Influenza Surveillance & Pandemic Influenza Preparedness Plan
$832,000Bernardus Ganter · World Health Organization · U51 · FY2006 · CI
Balancing epithelial cell resistance and resilience to respiratory viral infections
$831,352Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2025 · HL
Explore a key nucleotide synthesis enzyme to develop a broad-spectrum antiviral therapy.
$831,235Pinghui Feng · University Of Southern California · R01 · FY2025 · AI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$830,363Jennifer Eileen Adair · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Point of Care Detection of Respiratory Viruses
$830,014Thomas William Schoenfeld · Lucigen Corporation · R44 · FY2014 · AI
Flu vaccine effectiveness in thosehospitalized in a large diverse health system
$830,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · IP
Determining Influenza Vaccine Effectiveness (DIVE)
$830,000Helen Keipp Talbot · Vanderbilt University Medical Center · U01 · FY2019 · IP
US Hospital Vaccine Effectiveness (VE) Network
$829,998Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2019 · IP
Project II: Immunity to Influenza in Primary Lung Dendritic Cells
$829,779Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-
$828,847Robert Gerald Whalen · Altravax, Inc. · R01 · FY2015 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$828,793Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2022 · AI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
$828,717Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2024 · AI
Targeting Angiopoietin-like 4 (ANGPTL4) in Severe Community Acquired Pneumonia
$827,909Pavan Kumar Bhatraju · University Of Washington · R01 · FY2025 · HL
Antibody Responses in Aging SIV Infected Monkeys
$827,888Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2015 · AI
Viral Arrays for Biodefense
$827,411W. Ian Lipkin · Columbia University Health Sciences · U01 · FY2009 · AI
CAREER: Decoding the Code of Glycan-Collectin Interactions: Computational Engineering of Surfactant Proteins for Tailored Glycan Recognition
$827,316Mona S Minkara · Northeastern University · · FY2024 · ENG